Metagenomi Therapeutics, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Total Assets↓-31.9% -$103M
$221M
Current Assets↓-35.8% -$92M
$166M
Cash & Equivalents↑+52.3% +$14M
$42M
Receivables
$900K
Net PPE↓-30.7% -$5M
$12M
Total Liabilities↓-30.3% -$27M
$63M
Current Liabilities↓-38.5% -$14M
$23M
Account Payables↑+179.4% +$956K
$1M
Stockholders Equity↓-32.5% -$76M
$159M
Retained Earnings↓-39.4% -$88M
$-311M
Operating Lease ROU Asset↓-12.1% -$5M
$35M
Operating Lease Liability↑+1.2% +$471K
$41M
Finance Lease ROU Asset
$0
Gross PP&E↓-2.6% -$760K
$28M
Accumulated Depreciation↑+41.6% +$5M
$16M
Contract Asset
$0
Contract Liability↓-64.6% -$21M
$12M
Contract Liability (Current)↓-61.8% -$14M
$9M
Contract Liability (Noncurrent)↓-70.8% -$7M
$3M
Remaining Performance Obligation
$0